SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023

Rhea-AI Summary

SomaLogic, a leader in proteomics technology, has announced it will report its financial results for the first quarter of 2023 on May 11, 2023, after market close. A conference call will follow at 4:30 p.m. Eastern Time to discuss the financial metrics and insights. Interested participants are encouraged to register online more than 15 minutes prior to the call. The company focuses on delivering actionable health-management information through its SomaScan Platform, which measures changes in proteins over time. It operates under the Nasdaq ticker SLGC and emphasizes its commitment to empowering individuals to enhance their health and wellness. The SomaScan Platform is designated for research use only and is not FDA approved.

BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market close on Thursday, May 11, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived version of the webcast will be available at https://investors.somalogic.com/.   

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@somalogic.com

SomaLogic Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

FAQ

When will SomaLogic report its Q1 2023 financial results?

SomaLogic will report its Q1 2023 financial results on May 11, 2023, after market close.

What time is the SomaLogic Q1 2023 conference call?

The SomaLogic conference call for Q1 2023 will begin at 4:30 p.m. Eastern Time on May 11, 2023.

How can I participate in the SomaLogic conference call?

Participants can register for the conference call online, with a recommendation to do so at least 15 minutes before it begins.

What does SomaLogic's SomaScan Platform do?

The SomaScan Platform measures important changes in proteins over time to provide actionable health-management information.

Is the SomaScan Platform FDA approved?

No, the SomaScan Platform is for research use only and has not been cleared or approved by the FDA.